Elevance Health, Inc.
Company Stats
- Market Cap
- $84.3B
- as of Sep 30, 2026
- Shares Outstanding
- 216.9M
- Free Float
- 99.8%
Income Statement
- Revenue
- $199.1B
- Operating Income
- $7.2B
- Net Income
- $5.7B
- EBITDA
- $8.7B
- Non-cash Impairment
- $108.0M
- Revenue Growth, 3Y
- 8.3%
- FCF Margin, 3Y Avg
- 2.7%
- FCF Margin, Worst Year
- 1.6%
Cash Flow
- Free Cash Flow
- $3.2B
- FCF Yield
- 3.8%
- Owner FCF Yield
- 3.4%
Balance Sheet
- Cash & Equivalents
- $9.5B
Returns & Capital
- Dividends Paid
- $1.5B
- Dividend Yield
- 1.8%
- Dividend Payout, 3Y Avg
- 25.2%
- Share Repurchases
- $2.6B
- Buyback Yield, 3Y Avg
- 3.2%
- SBC, 3Y Avg
- $252.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $199.1B | $3.2B | 1.6% |
| FY2024 | $177.0B | $4.6B | 2.6% |
| FY2023 | $171.3B | $6.8B | 3.9% |
| FY2022 | $156.6B | $7.2B | 4.6% |
| FY2021 | $138.6B | $7.3B | 5.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
Elevance Health Insiders Lead Weekly Buying Clusters